| Literature DB >> 24902694 |
Francesco Vierucci1, Marta Del Pistoia, Margherita Fanos, Paola Erba, Giuseppe Saggese.
Abstract
BACKGROUND: Vitamin D plays an important role in health promotion during adolescence. Vitamin D deficiency and insufficiency are common in adolescents worldwide. Few data on vitamin D status and risk factors for hypovitaminosis D in Italian adolescents are currently available.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24902694 PMCID: PMC4064504 DOI: 10.1186/1824-7288-40-54
Source DB: PubMed Journal: Ital J Pediatr ISSN: 1720-8424 Impact factor: 2.638
Characteristics of the subjects
| Age, years | 427 | 14.3 (10.0; 21.0) |
| Height, SDS | 366 | -0.4 (-2.1; 2.4) |
| Weight, SDS | 366 | 0.4 (-2.1; 3.8) |
| BMI, SDS | 366 | 0.8 (-2.2; 3.9) |
| Calcium intake, mg/day | 277 | 609.6 (200.2; 1,280.9) |
| Vitamin D intake, IU/day | 277 | 14.8 (2.4; 282.8) |
Serum 25-OH-D levels and vitamin D status related to presumed risk factors for hypovitaminosis D
| | | | | | | | |
| Male | 213/427 (50.0) | 48.3 (10.0; 174.7) | 0.438 | 111/213 (52.1) | 62/213 (29.1) | 40/213 (18.8) | 0.366 |
| Female | 214/427 (50.0) | 50.4 (8.1; 174.3) | | 102/214 (47.7) | 76/214 (35.5) | 36/214 (16.8) | |
| | | | | | | | |
| Urban | 238/427 (55.7) | 48.0 (10.8; 174.7) | 0.481 | 124/238 (52.1) | 73/238 (30.7) | 41/238 (17.2) | 0.583 |
| Rural | 189/427 (44.3) | 50.7 (8.1; 144.8) | | 89/189 (47.1) | 65/189 (34.4) | 35/189 (18.5) | |
| | | | | | | | |
| Winter (Jan – Mar) | 138/427 (32.3) | 41.8 (8.1; 100.9) | <0.0001 | 84/138 (60.9) | 38/138 (27.5) | 16/138 (11.6) | <0.0001 |
| Spring (Apr – Jun) | 110/427 (25.8) | 47.6 (12.1; 122.3) | | 63/110 (57.3) | 36/110 (32.7) | 11/110 (10.0) | |
| Summer (Jul – Sep) | 62/427 (14.5) | 63.7 (10.8; 174.3) | | 21/62 (33.9) | 19/62 (30.6) | 22/62 (35.5) | |
| Fall (Oct – Dec) | 117/427 (27.4) | 55.7 (12.0; 174.7) | | 45/117 (38.5) | 45/117 (38.5) | 28/117 (23.0) | |
| | | | | | | | |
| White | 410/427 (96.0) | 50.6 (10.0; 174.7) | <0.0001 | 198/410 (48.3) | 137/410 (33.4) | 75/410 (18.3) | 0.005 |
| Non-white | 17/427 (4.0) | 28.2 (8.1; 86.2) | | 15/17 (88.2) | 1/17 (5.9) | 1/17 (5.9) | |
| | | | | | | | |
| Normal | 205/366 (56.0) | 51.7 (13.5; 174.7) | 0.032 | 95/205 (46.3) | 60/205 (29.3) | 50/205 (24.4) | 0.011 |
| Overweight | 78/366 (21.3) | 48.7 (10.0; 107.9) | | 42/78 (53.8) | 28/78 (35.9) | 8/78 (10.3) | |
| Obese | 83/366 (22.7) | 46.0 (10.8; 94.6) | | 48/83 (57.8) | 27/83 (32.5) | 8/83 (9.6) | |
| | | | | | | | |
| Low | 50/277 (18.1) | 34.6 (10.0; 97.7) | <0.0001 | 39/50 (78.0) | 9/50 (18.0) | 2/50 (4.0) | <0.0001 |
| Moderate | 77/277 (27.8) | 52.4 (13.5; 174.7) | | 34/77 (44.2) | 29/77 (37.7) | 14/77 (18.1) | |
| Good | 150/277 (54.1) | 54.3 (18.1; 144.8) | | 63/150 (42.0) | 47/150 (31.3) | 40/150 (26.7) | |
| | | | | | | | |
| Regular | 92/277 (33.2) | 45.7 (10.0; 97.7) | <0.0001 | 58/92 (63.0) | 29/92 (31.5) | 5/92 (5.5) | <0.0001 |
| Non regular | 185/277 (66.8) | 54.6 (18.1; 174.7) | | 78/185 (42.2) | 56/185 (30.3) | 51/185 (27.5) | |
| | | | | | | | |
| < 3 hours/weeks | 173/277 (62.5) | 47.7 (12.0; 174.3) | <0.0001 | 96/173 (55.5) | 52/173 (30.1) | 25/173 (14.4) | 0.001 |
| ≥ 3 hours/weeks | 104/277 (37.5) | 59.5 (10.0; 174.7) | | 38/104 (36.5) | 32/104 (30.8) | 34/104 (32.7) | |
| | | | | | | | |
| Positive | 62/277 (22.4) | 50.1 (13.5; 95.6) | 0.376 | 30/62 (48.4) | 23/62 (37.1) | 9/62 (14.5) | 0.231 |
| Negative | 215/277 (77.6) | 50.2 (10.0; 174.7) | 104/205 (48.4) | 61/215 (28.4) | 50/215 (23.2) |
Logistic regression for presumed risk factors for vitamin D deficiency (25-OH-D < 50 nmol/L) and hypovitaminosis D (25-OH-D < 75 nmol/L)
| | ||||||||
|---|---|---|---|---|---|---|---|---|
| -0.52 (0.28) | 0.60 | 0.34-1.03 | 0.063 | -0.43 (0.37) | 0.65 | 0.31-1.36 | 0.251 | |
| (female vs male) | ||||||||
| 0.01 (0.28) | 1.01 | 0.58-1.76 | 0.975 | 0.27 (0.37) | 1.30 | 0.63-2.70 | 0.477 | |
| (urban vs rural) | ||||||||
| 1.19 (0.30) | 3.31 | 1.82-6.01 | <0.0001 | 1.73 (0.40) | 5.64 | 2.59-12.27 | <0.0001 | |
| (winter-spring vs summer-fall) | ||||||||
| 0.41 (0.29) | 1.50 | 0.84-2.67 | 0.167 | 1.36 (0.48) | 3.89 | 1.54-9.88 | 0.004 | |
| (normal vs overweight-obese) | ||||||||
| 1.57 (0.41) | 4.78 | 2.15-10.63 | <0.0001 | 1.78 (0.79) | 5.94 | 1.25-28.17 | 0.025 | |
| (low vs moderate-good) | ||||||||
| 0.63 (0.31) | 1.87 | 1.02-3.41 | 0.042 | 1.77 (0.54) | 5.89 | 2.05-16.94 | 0.001 | |
| (regular vs non regular) | ||||||||
| 0.34 (0.30) | 1.40 | 0.78-2.52 | 0.261 | 0.25 (0.38) | 1.28 | 0.60-2.71 | 0.522 | |
| (< 3 vs ≥ 3 hours/week) | ||||||||
| -0.25 (0.33) | 0.78 | 0.41-1.49 | 0.448 | 0.38 (0.49) | 1.46 | 0.56-3.81 | 0.445 | |
| (positive vs negative) | ||||||||
| Hosmer and Lemeshow test p = 0.482 | Hosmer and Lemeshow test p = 0.564 | |||||||
C.I.: Coefficient Interval.
Figure 1Individual PTH levels according to serum 25-OH-D values. Circles over the horizontal line (65.0 ng/L) are subjects with secondary hyperparathyroidism. Vertical lines represent the 25-OH-D cut-off of 25, 50 and 75 nmol/L.
Figure 2Box plot of serum 25-OH-D and PTH levels according to the season of blood withdrawal. p < 0.0001 between groups for both.